Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Jai-Hyun Kim"'
Autor:
Steve P Crampton, Beibei Wu, Edward J Park, Jai-Hyun Kim, Candice Solomon, Marian L Waterman, Christopher C W Hughes
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e7841 (2009)
THE COMPLEXITY OF WNT SIGNALING LIKELY STEMS FROM TWO SOURCES: multiple pathways emanating from frizzled receptors in response to wnt binding, and modulation of those pathways and target gene responsiveness by context-dependent signals downstream of
Externí odkaz:
https://doaj.org/article/8caafeacfa914d7ba703151ced3b9d45
Supplemental Figure 1. Effect of TPT on VEGF levels in ovarian cancer cell Lines. Supplemental Figure 2. P53 knockdown reverses topotecan effects on downstream levels of p53 target transcripts BAX, CDKN1A, GADD45, and Thbs1. Supplemental Figure 3. TP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d55859d08adc5b38af1ac3fe430726d
https://doi.org/10.1158/1541-7786.22513273.v1
https://doi.org/10.1158/1541-7786.22513273.v1
Publikováno v:
Journal of Cancer and Tumor International. :39-47
Cell differentiation agent-2 (CDA-2) was a promising hypomethylating agent approved by the Chinese FDA for the therapy of MDS in China. The active components of CDA-2 are differentiation inducers (DIs) and differentiation helper inducers (DHIs). DIs
All Trans Retinoic Acid (ATRA) is a Differentiation Inducer (DI) of Acute Promyelocytic Leukemia (APL) with proven clinical utility. Its benefits for other types of Acute Myelocytic Leukemia (AML) have been limited. In APL, ATRA targets the PML-RARA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e210836a816aa25e249a2940cbc7bfbe
https://doi.org/10.9734/bpi/nfmmr/v11/3824f
https://doi.org/10.9734/bpi/nfmmr/v11/3824f
Publikováno v:
Communication Sciences & Disorders. 24:172-185
배경 및 목적: 단어 찾기 어려움이나 이름대기 장애는 노화과정에서 빈번히 관찰된다. 치매나 인지장애로 진행하기 전, 전임상단계의 장노년층에게 이름대기 어려움에 대한 중재를 실시하
Cell differentiation agent-2(CDA-2) was a preparation of urinary differentiation inducers (DIs) and differentiation helper inducers (DHIs), which was a promising hypomethylating agent approved by the Chinese FDA for the therapy of myelodysplastic syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5f8683349f8890cd4368cfbd854f4a
https://doi.org/10.9734/bpi/hmmr/v2/2371e
https://doi.org/10.9734/bpi/hmmr/v2/2371e
Publikováno v:
Online Journal of Complementary & Alternative Medicine. 2
Publikováno v:
Cancer Research. 80:4098-4098
Background: Although enzalutamide (ENZ) is an effective treatment for prostate cancer (PC), development of ENZ resistance is inevitable. One mechanism for resistance is upregulation of ARV7, a splice variant of the full-length androgen receptor (FLAR
Autor:
Waun Ki Hong, Seung Hyun Oh, Merril S. Kies, Woo-Young Kim, Ho-Young Lee, Pinchas Cohen, Maher N. Younes, Jai-Hyun Kim, Adel K. El-Naggar, Fadlo R. Khuri, Jeffrey N. Myers
Publikováno v:
Clinical Cancer Research. 25:4861-4861
Autor:
Jai-Hyun Kim1, Eun-Ha Hwang1, Hye-Jung Park,2, Young-Ki Paik1, Yhong-Hee Shim2 yshim@konkuk.ac.kr
Publikováno v:
Molecules & Cells (Springer Nature). 2005, Vol. 19 Issue 2, p279-282. 4p.